ebook Munafa Stock Market Course + Intraday & FNO calls  

       

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

EDIT NEWS reasons for why stock price of Editas Medicine, Inc. is falling or rising

EDIT Editas Medicine is falling or rising technical reasons

Technical analysis forecast for Editas Medicine Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Editas Medicine EDIT at this time. Stock is falling and might fall more.

It appears as if Editas Medicine EDIT gave a large move recently.

Stock of Editas Medicine (EDIT) is trading below an important moving average line, and it has been below this line for quite some time now. This is not a good sign, stock might keep falling and stock might move lower...

My analysis of Editas Medicine is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 2.5 as stoploss in an intra day buy trade for a target of 2.81. However, stock will show a bearish move below 2.5.

EDIT Editas Medicine is falling or rising NEWS fundamental reasons

Formal retail credit access doubles over past decade India’s formal retail credit market has expanded sharply over the past decade, with credit access rising from 35% of consumers in 2017 to 74% in 2026, according to TransUnion CIBIL. Consumption-led loans such as personal loans, credit cards and consumer du - NEWS as on 2026-07-31 indiatimes.com

AI Big Short? Why rising credit default swaps are spooking investors and how is it similar to 2008 housing crisis Rising credit default swaps on major technology companies are fuelling concerns over a potential AI-driven market correction. Investors are drawing parallels with Michael Burry’s successful 2008 bet, while surging AI spending, leverage and elevated valuati - NEWS as on 2026-07-30 indiatimes.com

Cards continue to fly; credit goes to the big players The additions were led, once again, by the country's largest issuers. HDFC Bank topped the list, adding 163,000 net new credit cards and edging past SBI Cards, which added 162,000. ICICI Bank added 151,000 cards, while Federal Bank continued its strong mom - NEWS as on 2026-07-27 indiatimes.com

Bank credit growth eases to 17.7% in fortnight to July 15 Bank credit growth saw a slight deceleration to 17.7 percent year-on-year. Deposit growth also moderated to 12.7 percent in the same period. Outstanding bank credit reached Rs 217.3 lakh crore by mid-July. Deposits stood at Rs 262.9 lakh crore, maintaining - NEWS as on 2026-07-24 indiatimes.com

India in strongest credit growth phase since 2012 on robust corporate demand: Report India's credit expansion is currently its strongest since 2012. Corporate loan growth reached a thirteen-year high in May. Household loan growth has also remained resilient for four months. Non-banking financial companies saw retail loan growth accelerate - NEWS as on 2026-07-23 indiatimes.com

Purple Finance to acquire Saksham Gram Credit for rural expansion Purple Finance plans to acquire Saksham Gram Credit for rural market expansion. The company also secured equity funding of Rs 108 crore for growth. This acquisition will mark Purple Finance's entry into rural and semi-urban lending. Combined Assets Unde - NEWS as on 2026-07-22 indiatimes.com

Global Market: Euro zone banks tighten credit standards amid geopolitical risks, ECB survey shows Euro zone banks tightened lending standards in the second quarter as geopolitical uncertainty and economic risks prompted greater caution, according to the ECB's latest Bank Lending Survey. While demand for business loans improved, lenders became more sele - NEWS as on 2026-07-21 indiatimes.com

More announcements and NEWS

EDIT Editas Medicine, Inc. current price & indicator signals

Moving Averages for Editas Medicine, Inc.

  • 5Day Average: 2.63
  • 12Day Average: 2.72
  • 20Day Average: 2.94
  • 50Day Average: 2.92
  • 100Day Average: 2.87
  • 150Day Average: 2.59
  • 200Day Average: 2.62

EDIT Indicators & signals

Indicator MACD (12,26,9)

2.74, 2.86, -0.07
Indicator MACD is in negative zone

Indicator ADX (14)

0, 33.33, 33.33
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 52
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of EDIT Editas Medicine, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
31 Fri Jul 2026 2.58 2.53 to 2.71 -4.09% 0.85 times
30 Thu Jul 2026 2.69 2.60 to 2.71 3.46% 0.74 times
29 Wed Jul 2026 2.60 2.53 to 2.66 -0.76% 1.36 times
28 Tue Jul 2026 2.62 2.52 to 2.77 -2.24% 1.01 times
27 Mon Jul 2026 2.68 2.60 to 2.73 3.08% 0.66 times
24 Fri Jul 2026 2.60 2.59 to 2.76 0% 1.35 times
24 Fri Jul 2026 2.60 2.59 to 2.76 -4.41% 1.35 times
23 Thu Jul 2026 2.72 2.69 to 2.82 -2.16% 1.06 times
22 Wed Jul 2026 2.78 2.73 to 2.89 -3.81% 0.92 times
21 Tue Jul 2026 2.89 2.82 to 2.96 0.35% 0.7 times
20 Mon Jul 2026 2.88 2.85 to 3.07 -3.36% 0.84 times
17 Fri Jul 2026 2.98 2.77 to 3.03 3.47% 1.55 times

Videos related to: EDIT NEWS why is Editas Medicine, Inc. price falling or rising

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Hindi Basics How To Trade In FnO Futures Options Stock Market

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

 

Back to top